FDA proposes a new Experimental Study of Risk Information Amount and Location in Direct-to-Consumer (DTC) Print Ads that is intended to research wheth...
FDA accepts for review a UCB NDA for midazolam nasal spray, an investigational product for the acute treatment of seizures in patients who require con...
FDA Review posts the Federal Register notices for the week ending 8/21/2018.
FDA releases a new draft guidance that is intended to modernize clinical trial designs in oncology drug development.
Federal Register notice: FDA announces a 9/10 public workshop entitled Human Dermal (Skin) Safety Testing for Topical Drug Products: Regulatory Utilit...
FDA approves an Alnylam Pharmaceuticals NDA for Onpattro (patisiran) infusion for treating peripheral nerve disease caused by hereditary transthyretin...
Federal Register notice: FDA submits to OMB a new information collection study entitled Disclosures in Professional and Consumer Prescription Drug Pro...
FDA approves a Population Council NDA for Annovera, first vaginal ring contraceptive that can be used for an entire year.